Skip to main content

Table 2 Pharmacokinetic (PK) model parameter estimates and stability of the parameters using bootstrap validation (BS)

From: Population pharmacokinetic-pharmacodynamic model of propofol in adolescents undergoing scoliosis surgery with intraoperative wake-up test: a study using Bispectral index and composite auditory evoked potentials as pharmacodynamic endpoints

Parameter

PK Model

BS PK Model

Mean (CV%)

Mean (CV%)

Fixed effects

 CL (l/min)

1.37 (7.0)

1.38 (5.1)

 Q (l/min)

1.15 (29.4)

1.16 (44.1)

 V1 (l)

3.6 (10.2)

3.45 (11.3)

 V2 (l)

76.8 (5.0)

77.3 (5.0)

Interindividual variability

 ω2 of CL in %

22.1 (28.7)

21.4 (25.7)

 Residual error

 σ2

19.0% (11.9)

18.4% (12.5)

Performance measures

 (−2LL)

− 452

− 464.7

  1. BS bootstrap validation, CL clearance, Q intercompartmental clearance, V1 central volume, V2 peripheral volume, ω2 variance, the square root of the exponential variance of η-1 is the percentage of the interindividual variability in the pharmacokinetic parameters; σ2 proportional individual variance, -2LL objective function. Values in parentheses are coefficient of variation (CV) of the parameter values